Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limb-girdle Muscular Dystrophy”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04800874
What this trial is testing

Study of BBP-418 in Patients With LGMD2I

Who this might be right for
LGMD2I
ML Bio Solutions, Inc. 14
Early research (Phase 1)Study completedNCT05286281
What this trial is testing

Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803

Who this might be right for
Healthy
Pfizer 6
Not applicableLooking for participantsNCT00390104
What this trial is testing

Molecular Analysis of Patients With Neuromuscular Disease

Who this might be right for
Neuromuscular; Disorder, HereditaryDuchenne/Becker Muscular DystrophyLimb-girdle Muscular Dystrophy
Boston Children's Hospital 1,000
Not applicableStudy completedNCT01081080
What this trial is testing

Cardiac Magnetic Resonance in Children With Muscular Dystrophy

Who this might be right for
Duchenne Muscular DystrophyBecker Muscular DystrophyLimb Girdle Muscular Dystrophy
Cooperative International Neuromuscular Research Group 20
Not applicableUnknownNCT01740908
What this trial is testing

Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments

Who this might be right for
Changes in Peripheral Blood Population Numbers and Type.
Restorix Research Institute, LLLP 8
Large-scale testing (Phase 3)Ended earlyNCT03439514
What this trial is testing

ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

Who this might be right for
Dilated CardiomyopathyLamin A/C Gene Mutation
Pfizer 77
Testing effectiveness (Phase 2)Study completedNCT02836418
What this trial is testing

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular DystrophyLimb Girdle Muscular Dystrophy
aTyr Pharma, Inc. 8
Not applicableActive Not RecruitingNCT06390566
What this trial is testing

Evolution of the Functional and Muscular State of Patients With Muscular Dystrophy 2A Belts

Who this might be right for
Limb Girdle Muscular Dystrophy
Assistance Publique - Hôpitaux de Paris 25
Early research (Phase 1)WithdrawnNCT02050776
What this trial is testing

Stem Cell Therapy in Limb Girdle Muscular Dystrophy

Who this might be right for
Limb Girdle Muscular Dystrophy
Neurogen Brain and Spine Institute
Testing effectiveness (Phase 2)Study completedNCT00104078
What this trial is testing

Study Evaluating MYO-029 in Adult Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyFacioscapulohumeral Muscular DystrophyLimb-Girdle Muscular Dystrophy
Wyeth is now a wholly owned subsidiary of Pfizer 108
Not applicableEnrolling By InvitationNCT04824040
What this trial is testing

Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF

Who this might be right for
DysferlinopathyMiyoshi MyopathyLGMDR2+1 more
Artgen Biotech 100
Early research (Phase 1)Study completedNCT00873782
What this trial is testing

Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy

Who this might be right for
Muscular DystrophiesDuchenne Muscular DystrophyBecker Muscular Dystrophy+1 more
University of North Carolina, Chapel Hill 16
Not applicableUnknownNCT03492346
What this trial is testing

Limb Girdle Muscular Dystrophy Type 2E Recruitment Study

Who this might be right for
Limb-Girdle Muscular Dystrophy, Type 2E
Nationwide Children's Hospital 25
Large-scale testing (Phase 3)Study completedNCT02285062
What this trial is testing

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Celgene 570
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableUnknownNCT04001595
What this trial is testing

Global FKRP Registry

Who this might be right for
LGMD2ILGMDR9Limb Girdle Muscular Dystrophy+4 more
Newcastle University 1,000
Early research (Phase 1)Study completedNCT02710500
What this trial is testing

RAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies

Who this might be right for
Dysferlinopathy
Sarepta Therapeutics, Inc. 2
Testing effectiveness (Phase 2)UnknownNCT05588401
What this trial is testing

Evaluating Safety and Efficacy of Autologous Gene-edited Muscle Stem Cells (GenPHSats-bASKet)

Who this might be right for
LGMD
Simone Spuler, MD 6
Testing effectiveness (Phase 2)Ended earlyNCT03652259
What this trial is testing

Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)

Who this might be right for
Limb-Girdle Muscular Dystrophy, Type 2E
Sarepta Therapeutics, Inc. 6
Load More Results